Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2013, Article ID 404396, 6 pages
http://dx.doi.org/10.1155/2013/404396
Clinical Study

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer

Department of Radiation & Oncology, Cancer Research Center, Shohadaye-Tajrish Hospital of Shahid Beheshti University of Medical Sciences and Health Services, Tajrish Square, Tehran, Iran

Received 23 June 2013; Revised 15 August 2013; Accepted 25 August 2013

Academic Editor: Zsuzsanna Kahán

Copyright © 2013 Hamid Reza Mirzaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hamid Reza Mirzaei, Parisa Sabet Rasekh, Fatemeh Nasrollahi, et al., “Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer,” International Journal of Breast Cancer, vol. 2013, Article ID 404396, 6 pages, 2013. https://doi.org/10.1155/2013/404396.